Yahui Huang

788 total citations
29 papers, 667 citations indexed

About

Yahui Huang is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Yahui Huang has authored 29 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 14 papers in Organic Chemistry and 6 papers in Infectious Diseases. Recurrent topics in Yahui Huang's work include Histone Deacetylase Inhibitors Research (8 papers), Quinazolinone synthesis and applications (7 papers) and Cancer therapeutics and mechanisms (5 papers). Yahui Huang is often cited by papers focused on Histone Deacetylase Inhibitors Research (8 papers), Quinazolinone synthesis and applications (7 papers) and Cancer therapeutics and mechanisms (5 papers). Yahui Huang collaborates with scholars based in China, United States and Taiwan. Yahui Huang's co-authors include Chunquan Sheng, Guoqiang Dong, Shanchao Wu, Wannian Zhang, Shuqiang Chen, Na Liu, Huanqiu Li, Jie Tu, Yu Li and Lei Wang and has published in prestigious journals such as PLoS ONE, Advanced Drug Delivery Reviews and Journal of Medicinal Chemistry.

In The Last Decade

Yahui Huang

28 papers receiving 664 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yahui Huang China 14 441 230 124 66 59 29 667
Shuo Yuan China 18 415 0.9× 383 1.7× 133 1.1× 47 0.7× 34 0.6× 73 933
Naval Kapuriya India 15 274 0.6× 346 1.5× 119 1.0× 35 0.5× 37 0.6× 40 635
Hongjiang Xu China 15 373 0.8× 192 0.8× 106 0.9× 27 0.4× 36 0.6× 41 773
Yu-Shan Wu Taiwan 10 281 0.6× 199 0.9× 185 1.5× 79 1.2× 18 0.3× 10 644
Jü Zhu China 15 250 0.6× 170 0.7× 100 0.8× 74 1.1× 29 0.5× 34 435
Anhui Gao China 14 390 0.9× 125 0.5× 75 0.6× 29 0.4× 41 0.7× 30 680
Christine Basmadjian France 10 417 0.9× 86 0.4× 106 0.9× 34 0.5× 53 0.9× 11 588
Shigeki Kashimoto Japan 14 339 0.8× 243 1.1× 185 1.5× 21 0.3× 118 2.0× 21 733

Countries citing papers authored by Yahui Huang

Since Specialization
Citations

This map shows the geographic impact of Yahui Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yahui Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yahui Huang more than expected).

Fields of papers citing papers by Yahui Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yahui Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yahui Huang. The network helps show where Yahui Huang may publish in the future.

Co-authorship network of co-authors of Yahui Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Yahui Huang. A scholar is included among the top collaborators of Yahui Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yahui Huang. Yahui Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Tingting, Jie Tu, Peng Zou, et al.. (2025). Discovery of New Pyrazolone Carbothioamide Derivatives as Potent Antifungal Agents for the Treatment of Candidiasis and Cryptococcosis. Journal of Medicinal Chemistry. 68(8). 8439–8454. 2 indexed citations
2.
Hu, Weijie, Jing Shen, Chenchen Zhou, et al.. (2024). Discovery of Janus Kinase and Histone Deacetylase Dual Inhibitors as a New Strategy to Treat Psoriasis. Journal of Medicinal Chemistry. 67(21). 19267–19281. 3 indexed citations
3.
Huang, Yahui, Fangfang Wang, Jie Hong, et al.. (2023). Discovery of potent natural product higenamine derivatives as novel Anti-Fusobacterium nucleatum agents. Bioorganic Chemistry. 138. 106586–106586. 3 indexed citations
4.
Huang, Yahui, Chenchen Zhou, Guoqiang Dong, et al.. (2023). Discovery of Dual Function Agents That Exhibit Anticancer Activity via Catastrophic Nicotinamide Adenine Dinucleotide Depletion. Journal of Medicinal Chemistry. 66(24). 16694–16703. 4 indexed citations
6.
Zhou, Chenchen, Fangfang Wang, Jie Hong, et al.. (2023). Discovery of New Fusobacterium nucleatum Inhibitors to Attenuate Migratory Capability of Colon Cancer Cells by the Drug Repositioning Strategy. Journal of Medicinal Chemistry. 66(23). 15699–15714. 10 indexed citations
7.
Tu, Jie, Tianbao Zhu, Qingwen Wang, et al.. (2023). Discovery of a new chemical scaffold for the treatment of superbug Candida auris infections. Emerging Microbes & Infections. 12(1). 2208687–2208687. 4 indexed citations
8.
Liu, Na, Jie Tu, Yahui Huang, et al.. (2023). Target- and prodrug-based design for fungal diseases and cancer-associated fungal infections. Advanced Drug Delivery Reviews. 197. 114819–114819. 15 indexed citations
9.
Huang, Yahui, et al.. (2023). BET–HDAC Dual Inhibitors for Combinational Treatment of Breast Cancer and Concurrent Candidiasis. Journal of Medicinal Chemistry. 66(2). 1239–1253. 27 indexed citations
10.
Wu, Shanchao, Yahui Huang, Ting Wang, et al.. (2022). Evodiamine-Inspired Topoisomerase-Histone Deacetylase Dual Inhibitors: Novel Orally Active Antitumor Agents for Leukemia Therapy. Journal of Medicinal Chemistry. 65(6). 4818–4831. 28 indexed citations
11.
Xu, Tian‐Ying, Peng Wang, Shu‐Na Wang, et al.. (2021). Pharmacological characterization of MT-1207, a novel multitarget antihypertensive agent. Acta Pharmacologica Sinica. 42(6). 885–897. 7 indexed citations
12.
Huang, Yahui, Kun Wan, Chunquan Sheng, et al.. (2021). Structural simplification of evodiamine: Discovery of novel tetrahydro-β-carboline derivatives as potent antitumor agents. Bioorganic & Medicinal Chemistry Letters. 40. 127954–127954. 11 indexed citations
13.
Wu, Ying, Lei Wang, Yahui Huang, et al.. (2019). Nicotinamide Phosphoribosyltransferase (NAMPT) Is a New Target of Antitumor Agent Chidamide. ACS Medicinal Chemistry Letters. 11(1). 40–44. 13 indexed citations
14.
Wang, Lei, Kun Fang, Junfei Cheng, et al.. (2019). Scaffold Hopping of Natural Product Evodiamine: Discovery of a Novel Antitumor Scaffold with Excellent Potency against Colon Cancer. Journal of Medicinal Chemistry. 63(2). 696–713. 66 indexed citations
15.
Huang, Yahui, Guoqiang Dong, Huanqiu Li, et al.. (2018). Discovery of Janus Kinase 2 (JAK2) and Histone Deacetylase (HDAC) Dual Inhibitors as a Novel Strategy for the Combinational Treatment of Leukemia and Invasive Fungal Infections. Journal of Medicinal Chemistry. 61(14). 6056–6074. 91 indexed citations
16.
Huang, Yahui, Yu Li, Guoqiang Dong, et al.. (2018). Identification of pyrazolopyridine derivatives as novel spleen tyrosine kinase inhibitors. Archiv der Pharmazie. 351(8). 10 indexed citations
17.
Li, Xiaokang, Yahui Huang, Junfei Cheng, et al.. (2018). Discovery of novel Syk/PDGFR-α/c-Kit inhibitors as multi-targeting drugs to treat rheumatoid arthritis. Bioorganic & Medicinal Chemistry. 26(15). 4375–4381. 7 indexed citations
18.
Huang, Yahui, Youjun Zhang, Guoqiang Dong, et al.. (2017). Discovery of new Syk inhibitors through structure-based virtual screening. Bioorganic & Medicinal Chemistry Letters. 27(8). 1776–1779. 10 indexed citations
19.
He, Shipeng, Guoqiang Dong, Zhibin Wang, et al.. (2015). Discovery of Novel Multiacting Topoisomerase I/II and Histone Deacetylase Inhibitors. ACS Medicinal Chemistry Letters. 6(3). 239–243. 63 indexed citations
20.
Wu, Keng‐Liang, Eng‐Yen Huang, Yahui Huang, et al.. (2012). Overexpression of galectin-3 enhances migration of colon cancer cells related to activation of the K-Ras–Raf–Erk1/2 pathway. Journal of Gastroenterology. 48(3). 350–359. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026